NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE19671 Query DataSets for GSE19671
Status Public on Dec 29, 2009
Title Promoter hypermethylation in MLL-r leukemia: biology and therapeutic targeting
Organism Homo sapiens
Experiment type Methylation profiling by genome tiling array
Summary MLL-r infant acute lymphoblastic leukemia (ALL) has largely unclear oncogenesis. It has been shown unrelated to copy number change or mutations in the tyrosine kinome. We therefore, explored the possible role of genome wide CpG island hypermethylation in MLL-r infant ALL. We employed the HpaII-tiny fragment Enrichment by Ligation-mediated PCR (HELP) assay to examine MLL-r infant leukemia samples (n=5), other common childhood ALL (n=5) and normals (n=5). We then investigated biological correlation and the therapeutic potential of 5-aza-2’-deoxycytidine (decitabine). Analysis of the HELP assay showed both tight clustering of samples into their biological groups and that MLL-r infant leukemia was globally and comparatively hypermethylated. Further, a majority of genes chosen for analysis from the HELP assay were silenced or under-expressed. MLL-r cell lines showed dose and time-dependent cell kill when treated with decitabine and most down-regulated genes showed increase in expression. This was not seen in the MLL-wt cell line. For the re-expressed genes, methylation specific PCR confirmed preferential promoter methylation in MLL-r samples. Together, this suggests that methylation signatures are unique in pediatric ALL, that promoter hypermethylation may play a significant role in MLL-r infant leukemogenesis, that this can be reversed and demethylating agents may be a potential new therapeutic option in infant leukemia.

Keywords: DNA methylation profiling
 
Overall design Direct comparison of DNA methylation in leukemic blasts from 5 infants with MLL-r ALL with 5 children with other common types of ALL and 5 normal samples consisting of CD34+ selected cord blood cells (n=3) and CD19+ selected cord blood cells (n=2)
 
Contributor(s) Schafer ES, Figueroa ME, Melnick A, Brown P
Citation(s) 20215641
Submission date Dec 28, 2009
Last update date Mar 21, 2012
Contact name Eric Stephen Schafer
E-mail(s) eschafe1@jhmi.edu
Phone (410) 955-8817
Fax (410) 955-8897
Organization name Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Department Pediatrics and Oncology
Lab Patrick Brown Laboratory
Street address CRB1, Room 252a, 1650 Orleans St.
City Baltimore
State/province MD
ZIP/Postal code 21287
Country USA
 
Platforms (1)
GPL6604 HG17_HELP_Promoter
Samples (15)
GSM491117 251493-ES-rehyb-4-080923
GSM491118 251278-ES-rehyb-1-080923
GSM491119 256564-ES-2R-090108
Relations
BioProject PRJNA122493

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE19671_RAW.tar 230.2 Mb (http)(custom) TAR (of PAIR)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap